You Jeong Lee Selected Research

Immune Checkpoint Inhibitors

1/2021

Crystal structure of human interleukin-2 in complex with TCB2, a new antibody-drug candidate with antitumor activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

You Jeong Lee Research Topics

Disease

9	Neoplasms (Cancer) 08/2023 - 01/2018
3	Adenocarcinoma 08/2023 - 10/2018
3	Inflammation (Inflammations) 01/2022 - 01/2018
3	Infections 01/2021 - 11/2013
2	Carcinoma (Carcinomatosis) 04/2019 - 08/2009
2	Body Weight (Weight, Body) 01/2018 - 01/2018
1	Neuroinflammatory Diseases 01/2023
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2023
1	Encephalomyelitis (Myeloencephalitis) 01/2023
1	Pain (Aches) 12/2022
1	Fibrosis (Cirrhosis) 12/2022
1	Cystitis 12/2022
1	Hyponatremia 12/2022
1	Anaphylaxis (Anaphylactic Shock) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Alopecia Areata 01/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	COVID-19 01/2021
1	Hypoxia (Hypoxemia) 01/2018
1	Colitis 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Edema (Dropsy) 01/2018
1	Fatty Liver 01/2018
1	Carcinogenesis 01/2018
1	Heart Failure 01/2018
1	Hemorrhage 01/2018
1	Hyperlipidemias (Hyperlipidemia) 01/2018
1	Insulin Resistance 01/2018
1	Obesity 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Dyslipidemias (Dyslipidemia) 01/2018
1	Papilloma (Papillomatosis) 08/2009
1	Virus Diseases (Viral Diseases) 01/2009
1	Uterine Cervical Dysplasia 08/2006
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2006
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2006

Drug/Important Bio-Agent (IBA)

6	GoldIBA 08/2023 - 01/2018
3	Interleukin-2 (IL2)IBA 01/2022 - 01/2020
2	AntigensIBA 01/2023 - 01/2016
2	thiazolyl blueIBA 01/2022 - 04/2019
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2020
2	ChitosanIBA 01/2022 - 04/2019
2	AntibodiesIBA 01/2020 - 08/2006
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 01/2016
2	Interleukin-4 (Interleukin 4)IBA 01/2016 - 11/2013
1	graphene oxideIBA 08/2023
1	Docetaxel (Taxotere)FDA Link 08/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 08/2023
1	Interleukin-23 (Interleukin 23)IBA 01/2023
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023
1	Alanine Transaminase (SGPT)IBA 12/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2022
1	Evans Blue (Blue, Evans)FDA Link 12/2022
1	TeaIBA 12/2022
1	C-Reactive ProteinIBA 12/2022
1	CollagenIBA 12/2022
1	CreatinineIBA 12/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2022
1	CytokinesIBA 01/2022
1	Immunoglobulin E (IgE)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Particulate MatterIBA 01/2021
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2020
1	SilverIBA 05/2019
1	Reducing AgentsIBA 10/2018
1	Bovine Serum AlbuminIBA 10/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	Dextrans (Dextran)FDA Link 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Amodiaquine (Camoquin)FDA Link 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	LipidsIBA 01/2018
1	AzoxymethaneIBA 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2018
1	Proteins (Proteins, Gene)FDA Link 08/2009
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2009
1	ParaffinIBA 08/2006

Therapy/Procedure

2	Nanospheres 08/2023 - 04/2019
1	Aftercare (After-Treatment) 01/2022
1	Immunotherapy 01/2021